Participated · Seed · Jul 2026

Outlier Space is developing an autonomous returnable orbital capsule designed to carry research and manufacturing payloads into orbit for durations of weeks to months and then return them safely to Earth. The company says such microgravity conditions can produce purer crystals and more uniform protein structures, enabling scientific and manufacturing experiments that benefit from reduced gravity. Outlier positions its service as a landlord for specialized orbital factories that host those payloads. The team is led by founder Jamie France, who has prior experience at Emirates Team New Zealand, Air New Zealand’s Skycouch development, and nearly a decade at Rocket Lab culminating as Global Director of the Electron programme; team members named include Nick Pearson and Courtney France. Financially, Outlier closed a US$7.35M pre-seed round, noted as one of the largest pre-seed raises in New Zealand history, to fund development of the capsule and related operations.

Participated · Seed · Jul 2026

VXB offers a software platform that integrates physics, material composition, cost, and manufacturability to accelerate design and validation of complex aerospace components. The company reports its software is already in production use, delivering immediate value to customers across the aerospace industry. A major aerospace manufacturer has adopted VXB-designed component placements as standard practice and is proposing the platform for a deep-space program. A satellite hardware startup founded by SpaceX alumni became a paying customer after the platform solved longstanding design challenges. VXB plans to expand its engineering team, grow its defense and commercial customer base, and extend the platform to additional classes of complex components using the new funding.

Participated · Series A · Apr 2026

Syenta develops semiconductor packaging technology for the chip industry. The company recently raised $26 million in a funding round backed by a firm led by a former Intel CEO. It is expanding its physical presence by opening a 3,500-square-foot hub in Tempe (East Valley). The article focuses on this U.S. expansion and the new capital but does not provide revenue, user, or broader financial metrics. No founding year or additional operational metrics were included in the coverage. The raise and new facility indicate a move to scale operations and engage more directly with the U.S. market.

Participated · Series A · Apr 2026

Renewable Metals develops lithium‑ion battery recycling technology and modular commercial plants designed to recover critical minerals from spent batteries. The company reports it can recover about 95% of critical minerals and operate at roughly 50% lower operating costs than incumbent recyclers. It plans to expand production capacity in Australia and onshore recycling to avoid exporting battery waste to China. Renewable Metals positions its modular plants to scale into markets such as the EU, US and Australia as governments introduce recycled‑content mandates. Management and investors have framed the business as addressing geopolitical supply‑chain risks tied to critical minerals. The company’s recent $12M Series A will fund the next stage of commercial expansion.

Participated · Series B · Mar 2026

Founded in 2024, Lumonus offers an AI-native clinical care platform that streamlines end-to-end radiation oncology workflows. Its flagship products, Lumonus AI Physician and Lumonus AI Dosimetry, enable clinicians to consult and prescribe on cancer treatments more efficiently. The software is already deployed across the United States, Australia and Europe, where care teams have used it in more than 280,000 cancer treatment consultations and to automate over 75,000 treatment plans. With fresh funding, the company plans to expand its U.S. go-to-market and clinical success teams, bolster its clinical informatics capabilities, and further personalize its AI tools. Lumonus positions itself as a partner to oncology teams seeking data-driven, workflow-centric solutions. Financially, the startup has raised a total of $28 million in Series B financing, following a seed round backed by Oncology Ventures in March 2025.